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Review question
Types of participants: this review will include children aged 5 years or younger.
Types of exposure: mycotoxin exposure during pregnancy, lactation and childhood. Concentrations of
mycotoxin in the diet, breast milk, urine and blood will be taken into account.
This review will consider studies that include the following outcome measures:
• Child growth as measured by anthropometric measurements, such as weight for length/height, weight for
age, length/height for age, mid-upper arm circumference (MUAC) and head circumference.
• Morbidity: hepatic, gastrointestinal and respiratory diseases. Marasmus, kwashiorkor and marasmic-
kwashiorkor.
• Deaths occurring for children under ﬁve years of age: Perinatal mortality, neonatal mortality, infant mortality
and child mortality.
• Studies on immune system of under-ﬁves.
Setting There will be no restrictions by type of setting.
Searches
The databases to be searched will include: MEDLINE, EMBASE, Cochrane Library, CINAHL, Web of
Science, PsycINFO, grey literature through Google Scholar and reference lists to the papers reviewed. 
Studies published in English and French will be considered for inclusion in this review. There will be no date
restriction. 
The full search strategy in PubMed included MeSH-terms and text words. The search strategy will be
adapted as required for other electronic databases.  
Types of study to be included
This review will consider both experimental and observational study designs including randomized controlled
trials, non-randomized controlled trials, quasi-experimental studies, before and after studies, prospective
and retrospective cohort studies, case control studies and analytical cross-sectional studies.
Condition or domain being studied
Mycotoxins, child growth, morbidity and mortality. 
Participants/population
This review will include children aged 5 years or younger. 
Animal studies, drug trials, diagnostic trials and case reports will be excluded from the study review. Studies
only reporting qualitative results will not be retained.
Intervention(s), exposure(s)
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Many important agricultural products, especially those rich in carbohydrates, are attractive colonization sites
for fungi. Some toxic secondary metabolites of fungal growth are identiﬁed as mycotoxins, and may be found
to contaminate agricultural products .
The contamination by mycotoxins can occur during pre-harvest at farm level, after harvest handling, storage
and food processing. Among many mycotoxins, aﬂatoxins (AF) and fumonisins (FUM), are widespread in
major cash-crops, agricultural commodities and their products in Africa. AF are highly carcinogenic, cause
immune-system suppression, exert hepatocellular damage and even death in both humans and domestic
animals. Furthermore, in the past, AFs exposure has caused acute outbreaks resulting in many casualties.
Dietary exposure to AF in childhood occurs mainly through complementary infant foods and carryover via
breast milk. 
Comparator(s)/control
Not applicable
Primary outcome(s)
This review will consider studies that include the following outcome measures:
• Child growth as measured by anthropometric measurements, such as weight for length/height, weight for
age, length/height for age, mid-upper arm circumference (MUAC) and head circumference.
• Morbidity: hepatic, gastrointestinal and respiratory diseases. Marasmus, kwashiorkor and marasmic-
kwashiorkor.
• Deaths occurring for children under ﬁve years of age: perinatal mortality, neonatal mortality, infant mortality
and child mortality.
• Studies on immune system of under-ﬁves. 
Secondary outcome(s)
Not applicable 
Data extraction (selection and coding)
First, we will screen titles and abstracts retrieved through the search strategies in various electronic
bibliographic databases for inclusion, then full texts will be examined in detail and screened for eligibility. We
will hand search reference lists of eligible studies for additional articles. We will contact study authors and
will ask them to provide additional information and further relevant references, if necessary.
KT will perform initial screening of studies by title. Next, KT, MDB and CL will assess the abstracts and the
full text articles for eligibility. Every manuscript and paper will be reviewed by at least 2 reviewers at this
stage. In case of disagreement, PK will be consulted for ﬁnal decision.
Data will be extracted from articles using a template designed for this review. We will pilot the data collection
form in a few studies and modiﬁcations will be made where necessary. The data extraction will include
speciﬁc details about the author and year of publication, interventions/exposure, study population, study
methods and designs, study setting, sample size, outcome measurement, outcome measurement method,
biomarkers, outcomes of signiﬁcance to the review question and speciﬁc objectives.  
Risk of bias (quality) assessment
The methodological quality and bias of epidemiological studies will be evaluated using the Newcastle-
Ottawa scale for observational studies. Each study will be judged on various items, categorized into three
groups: the selection of the study groups, the comparability of the groups, the exposure and the outcome of
interest for observational studies. The reviewers will make decision on the classiﬁcation of risk of bias. The
quality (risk of bias) for each observational study will be independently assessed by two reviewers.
Discrepant scores will be resolved by discussion with a third reviewer.
To critically appraise the validity of each randomized and non-randomized trial included in this study, the
Cochrane Collaboration’s Risk of Bias Tool will be used.
Strategy for data synthesis
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Where appropriate meta-analyses will be done to quantify the results of different studies. We will use the I²
statistic to measure heterogeneity across studies. A random-effects meta-analysis will be used to
incorporate heterogeneity among studies. In case of substantial heterogeneity subgroup analysis will be
used. Separate sensitivity and/or sub-analyses will be conducted to assess heterogeneity.
We will estimate the effect of the intervention/exposure using odds ratios or risk ratio/risk difference for
dichotomous data, together with their respective conﬁdence intervals and mean difference or standardized
mean difference for continuous data, together with the 95% appropriate associated conﬁdence interval. 
Odds ratios will be used in cross-sectional or case-control studies. In any of the observational study designs
(cohort, case control and cross-sectional studies), funnel plots will be used to assess publication bias
provided that enough comparable studies are identiﬁed to conduct a meta-analysis.
Two review authors will independently assess the strength of the evidence (high, moderate, low, and very
low) using the recommendations of the GRADE working group i.e. risk of bias, consistency of effect,
imprecision, indirectness, and publication bias. Disagreements will be resolved through discussion with a
third reviewer.
When quantitative synthesis is either not appropriate or not feasible, narrative synthesis will be performed,
such as a structured summary and discussion of the studies’ characteristics and ﬁndings. Further analysis
will be performed depending on the type and nature of the data. We will contact investigators to obtain
missing outcome data if necessary.
Results of this study will be presented according to the PRISMA Statement.
Analysis of subgroups or subsets
If the necessary data are available, in case of substantial heterogeneity, subgroup analysis will be used.
Separate sensitivity and/or sub-analyses will be conducted to assess heterogeneity across methodological
factors such as study design, overall study quality, length of follow-up, types of intervention/exposure,
participant characteristics i.e. gender and nutritional status, geographical locations or type of variables. 
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